Posted by Clinical Lab Products | Jul 2, 2003 | Cancer, Miscellaneous |
By Ellen Blaine, M.P.H. The power and paradox of predictive medicine is that it can be used as an aid in the management of diseases that have not developed in an individual. As new genetic tests identify high risk for disease, methods can be sele
Read MorePosted by Clinical Lab Products | Jun 9, 2003 | Cancer, Miscellaneous |
PSA test for prostate cancer should be repeated before biopsy The prostate specific antigen (PSA) blood test is used in routine prostate cancer screening for men over 50, and elevated PSA levels typically result in referral for a prostate biopsy.
Read MorePosted by Clinical Lab Products | May 10, 2003 | Cancer, Miscellaneous |
HPV DNA Pap now approved for cervical cancer screening for all women over 30
Read MorePosted by Clinical Lab Products | Mar 10, 2003 | Heart Disease, Miscellaneous |
Long-term low-intensity warfarin therapy found highly effective in preventing recurrent VTE A new study led by Paul M. Ridker, M.D. of Brigham and Women’s Hospital and Harvard Medical School, has found that long-term, low-intensity warfarin t
Read MorePosted by Clinical Lab Products | Mar 2, 2003 | Miscellaneous |
New reference tests for mutations help assess drug metabolism and drug resistance
Read More